Hudson Bay Capital Management’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,831
| Closed | -$195K | – | 724 |
|
|
2023
Q2 | $195K | Buy |
+1,831
| New | +$195K | ﹤0.01% | 583 |
|
|
2022
Q1 | – | Sell |
-625
| Closed | -$203K | – | 1173 |
|
|
2021
Q4 | $203K | Sell |
625
-1,563
| -71% | -$508K | ﹤0.01% | 880 |
|
|
2021
Q3 | $1.06M | Sell |
2,188
-312
| -12% | -$151K | 0.01% | 710 |
|
|
2021
Q2 | $1.16M | Buy |
+2,500
| New | +$1.16M | 0.01% | 689 |
|